Trabectedin as a New Chemotherapy Option in the Treatment of Relapsed Platinum Sensitive Ovarian Cancer

Journal article

Peer reviewed

Bradley J. Monk, H. Dalton, I. Benjamin and A. Tanovic

Current Pharmaceutical Design, Vol.18(25), pp.3754-3796

2012

PMID: 22591421

Metrics

5 Record Views

Title: Trabectedin as a New Chemotherapy Option in the Treatment of Relapsed Platinum Sensitive Ovarian Cancer
Creators: Bradley J. Monk (Author) - Creighton University
H. Dalton (Author)
I. Benjamin (Author)
A. Tanovic (Author)
Publication Details: Current Pharmaceutical Design, Vol.18(25), pp.3754-3796
Number of pages: 3754-3796
Identifiers: 991005931375902656
Academic Unit: School of Medicine; Obstetrics & Gynecology
Resource Type: Journal article